Accreditation 

Florida State University College of Medicine maintains its full accreditation through the Liaison Committee on Medical Education (LCME), the recognized body for medical education programs in the United States, leading to the M.D. degree. The LCME is jointly sponsored by the AAMC and the American Medical Association (AMA). The next LCME site visit for the college is scheduled for April 12-14, 2027. Any questions regarding the accreditation status of the M.D. program at the FSU College of Medicine should be directed to lcme@aamc.org.

Preparing for Reaccreditation: The Self Study
Starting in January 2026, the college initiates its self-study process. This begins with forming a steering committee and multiple subcommittees, each examining a subset of the 12 LCME standards and their 93 elements. In this phase, faculty, staff, students, and administrators work together to: 
   • Collect and analyze data on every element of the curriculum and institutional structure
   • Perform an Independent Student Analysis (ISA) that allows students to evaluate the program and share candid  insights 
   • Identify institutional strengths, areas of concern, and opportunities for improvement
   • Develop actionable plans to maintain strength and resolve any issues
The result of this activity is a report that is submitted to the LCME.

Document Submission and Peer Review Visit
In addition to the self-study report, the college submits:
   1. The comprehensive Data Collection Instrument (DCI), which documents how each standard and element is met
   2. The ISA, authored by the student body
After a thorough review of all documents, the LCME peer review team will conduct a multi-day, on-site visit. Team members interview stakeholders, observe facilities, and assess the systems that are in place to maintain compliance with accreditation expectations.

FSU’s Accreditation History
   • 2005: The college receives notification that is has been granted full accreditation, making it the first new U.S. allopathic medical school to be established and accredited in more than 20 years. The February notification followed LCME’s November 2024 site visit.
   • 2011: The college became the first new 21st-century medical school to achieve full reaccreditation.
   • 2018–2019: The most recent self-study spanned nearly 18 months, culminating in an LCME site visit in April 2019. While the reaccreditation process was delayed due to the COVID pandemic, the college received notification of full accreditation through 2027.
   • 2026–27: The self-study and site visit cycle, which begins January 2026, aims to reaffirm the college’s adherence to all LCME standards.

Committing to Continuous Improvement
Accreditation transcends compliance, it reflects a culture of excellence and adaptability. At FSU, reaccreditation activities align with strategic goals, ensuring ongoing enhancement of the educational program in areas such as curriculum innovation, clinical training, and community service.
 
By transparently showcasing this rigorous, evidence-based process, the College of Medicine demonstrates its enduring commitment to educational quality, patient-centered training, and accountability to students, faculty, and the broader community.

J. Michael Overton, Ph.D.
Associate Dean for Continuous Quality Improvement

Shalon R. Buchs, Ed.D., PA-C
Director of Evaluation, Continuous Quality Improvement

College of Medicine CQI team
Members of the Continuous Quality Improvement team (from the left) include Aishwarya Sharma, J. Michael Overton, Tatiana Chavez de Daugherty, Sheldon White and Shalon R. Buchs.